Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic

Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic

Objective: to evaluate the accuracy of an antibody point-of-care lateral flow immunoassay (LFI - Wondfo Biotech Co., Guangzhou, China) in a pediatric population. Methods: children and adolescents (2 months to 18 years) with signs and symptoms suggestive of acute SARS-CoV-2 infection were prospective...

Full description

Bibliographic Details
Main Authors: Marcelo Comerlato Scotta, Caroline Nespolo de David, Fernanda Hammes Varela, Ivaine Tais Sauthier Sartor, Márcia Polese-Bonatto, Ingrid Rodrigues Fernandes, Gabriela Oliveira Zavaglia, Charles Francisco Ferreira, Luciane Beatriz Kern, Amanda Paz Santos, João Ronaldo Mafalda Krauzer, Paulo Márcio Pitrez, Walquiria Aparecida Ferreira de Almeida, Victor Bertollo Gomes Porto, Renato T. Stein
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Jornal de Pediatria
Subjects:
Children
SARS-CoV-2
COVID-19
Lateral flow immunoassay
Point-of-Care Testing
Online Access:http://www.sciencedirect.com/science/article/pii/S0021755721000838

Similar Items

Similar Items